The University of Notre Dame Australia

ResearchOnline@ND
Physiotherapy Papers and Journal Articles

School of Physiotherapy

2017

Safety and feasibility of transcranial direct current stimulation (tDCS)
combined with sensorimotor retraining in chronic low back pain: a protocol
for a pilot randomised controlled trial
A Ouellette
M Liston
W Chang
D Walton
B Wand
The University of Notre Dame Australia, benedict.wand@nd.edu.au

See next page for additional authors

Follow this and additional works at: https://researchonline.nd.edu.au/physiotherapy_article
Part of the Physical Therapy Commons, and the Physiotherapy Commons
This article was originally published as:
Ouellette, A., Liston, M., Chang, W., Walton, D., Wand, B., & Schabrun, S. (2017). Safety and feasibility of transcranial direct current
stimulation (tDCS) combined with sensorimotor retraining in chronic low back pain: a protocol for a pilot randomised controlled trial.
BMJ Open, Early View (Online First).
Original article available here:
http://dx.doi.org/10.1136/bmjopen-2016-013080

This article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/physiotherapy_article/114. For
more information, please contact researchonline@nd.edu.au.

Authors
A Ouellette, M Liston, W Chang, D Walton, B Wand, and S Schabrun

This article is available at ResearchOnline@ND: https://researchonline.nd.edu.au/physiotherapy_article/114

This is an Open Access article distributed in accordance with the Creative Commons Attribution-Non
Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this
work non-commercially, and license their derivative works on different terms provided the original
work is properly cited and the use is non-commercial.
See: https://creativecommons.org/licenses/by-nc/4.0/
This article originally published in BMJ Open available at:
http://dx.doi.org/10.1136/bmjopen-2016-013080
No changes have been made to this article.
Ouellette, A., Liston, M., Chang, W., Walton, D., Wand, B., and Schabrun, S. (2017) Safety and
feasibility of transcranial direct current stimulation (tDCS) combined with sensorimotor retraining in
chronic low back pain: a protocol for a pilot randomized controlled trial. BMJ Open, Online First. doi:
10.1136/bmjopen-2016-013080

Downloaded from http://bmjopen.bmj.com/ on September 18, 2017 - Published by group.bmj.com

Open Access

Protocol

Safety and feasibility of transcranial
direct current stimulation (tDCS)
combined with sensorimotor retraining
in chronic low back pain: a protocol for
a pilot randomised controlled trial
Adam Louis Ouellette,1 Matthew B Liston,1 Wei-Ju Chang,1 David M Walton,2
Benedict Martin Wand,3 Siobhan M Schabrun1

To cite: Ouellette AL,
Liston MB, Chang W-J,
et al. Safety and feasibility
of transcranial direct current
stimulation (tDCS) combined
with sensorimotor retraining
in chronic low back pain: a
protocol for a pilot randomised
controlled trial. BMJ Open
2017;7:e013080. doi:10.1136/
bmjopen-2016-013080
►► Prepublication history and
additional material is available.
To view please visit the journal
(http://dx.doi.org/ 10.1136/
bmjopen-2016-013080).

Received 23 November 2016
Revised 30 January 2017
Accepted 23 February 2017

1

Brain Rehabilitation and
Neuroplasticity Unit, School of
Science and Health, Western
Sydney University, Penrith, New
South Wales, Australia
2
School of Physiotherapy,
Western University, Elborn
College, London, Canada
3
The University of Notre Dame
Australia, The University of
Western Sydney, Penrith, New
South Wales, Australia
Correspondence to
Dr Siobhan M Schabrun;
s.schabrun@u ws.edu.au

ABSTRACT
Introduction Chronic low back pain (LBP) is a common
and costly health problem yet current treatments
demonstrate at best, small effects. The concurrent
application of treatments with synergistic clinical and
mechanistic effects may improve outcomes in chronic LBP.
This pilot trial aims to (1) determine the feasibility, safety
and perceived patient response to a combined transcranial
direct current stimulation (tDCS) and sensorimotor
retraining intervention in chronic LBP and (2) provide data
to support a sample size calculation for a fully powered
trial should trends of effectiveness be present.
Methods and analysis A pilot randomised, assessor and
participant-blind, sham-controlled trial will be conducted.
Eighty participants with chronic LBP will be randomly
allocated to receive either (1) active tDCS + sensorimotor
retraining or (2) sham tDCS + sensorimotor retraining.
tDCS (active or sham) will be applied to the primary motor
cortex for 20 min immediately prior to 60 min of supervised
sensorimotor retraining twice per week for 10 weeks.
Participants in both groups will complete home exercises
three times per week. Feasibility, safety, pain, disability and
pain system function will be assessed immediately before
and after the 10-week intervention. Analysis of feasibility
and safety will be performed using descriptive statistics.
Statistical analyses will be conducted based on intentionto-treat and per protocol and will be used to determine
trends for effectiveness.
Ethics and dissemination Ethical approval has been
gained from the institutional human research ethics
committee (H10184). Written informed consent will be
provided by all participants. Results from this pilot study
will be submitted for publication in peer-reviewed journals.
Trial registration number ACTRN12616000624482

Introduction
Low back pain (LBP) is one of the most
common reasons for people to seek
healthcare.1 Of those that report LBP,
44%–78% experience a re-occurrence within
12 months,2 and approximately 25% of individuals develop chronic pain.3 Despite high

Strengths and limitations of this study
►► A randomised, assessor and participant-blind,

sham-controlled trial that will provide the first
information on the feasibility and safety of a
combined transcranial direct current stimulation
and sensorimotor retraining intervention in chronic
low back pain.
►► This pilot trial is not powered to determine treatment
effectiveness. However, if trends of effectiveness are
present, these data will support a fully powered trial
in future.
►► The treating physiotherapist is not blinded to group
allocation.

prevalence, current treatments for chronic
LBP demonstrate, at best, small effect sizes.4 5
One avenue to improve outcomes in chronic
LBP is through the application of combined
treatments with synergistic clinical and mechanistic effects.
Sensorimotor retraining is a novel treatment that incorporates motor control
exercise and lumbar tactile retraining and
has been shown to be effective in early
randomised controlled trials and case studies
of chronic LBP.6–9 The mechanism underpinning improvements in pain and function with
sensorimotor retraining is thought to involve
normalisation of motor and sensory cortical
changes and improved pain system function.6 9 The addition of a second treatment
approach that targets synergistic mechanisms
may boost the effectiveness of sensorimotor
retraining in people with chronic LBP.
Transcranial direct current stimulation
(tDCS), a form of non-invasive brain stimulation, is thought to promote cortical
plasticity10–12 and improve pain system function through direct effects on the cortex and
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thalamus,13–19 as well as ‘downstream’ effects on the anterior cingulate cortex and upper brainstem.20 21 Studies of
healthy individuals and people with some forms of chronic
pain suggest that anodal tDCS applied to the primary
motor cortex can reduce pain.18 22–24 Indeed, a recent
systematic review in fibromyalgia demonstrates the effects
on pain that are analogous to those of FDA-approved
pharmaceuticals with considerably fewer side effects.25
In addition, the cortical effects of tDCS are hypothesised
to increase the brain’s receptiveness to other treatments,
a phenomenon known as priming.26 27 Based on these
mechanisms, tDCS may optimise the responsiveness of the
brain to sensorimotor retraining as well as target synergistic mechanisms of sensorimotor cortex reorganisation
promoted by sensorimotor retraining. The complementary mechanistic targets of these treatments may summate
to improve clinical outcomes beyond that which can be
achieved with sensorimotor retraining alone. Despite this,
no study has examined the effect of a combined tDCS and
sensorimotor retraining therapy in chronic pain.28–30
This pilot randomised controlled trial (RCT) protocol
will outline study methods and resources required to
determine the feasibility, acceptability and safety31 of
tDCS combined with sensorimotor retraining for people
with chronic LBP. This protocol uses a pain and neuroscience mechanisms approach to combine two treatments
with the potential to produce complementary and additive effects on sensorimotor cortical organisation and
pain system function. The specific aims are to (1) determine the feasibility, safety, perceived patient response to,
and acceptability of, a combined tDCS and sensorimotor
training intervention in chronic LBP and (2) provide data
to support a sample size calculation for a fully powered
trial should trends of effectiveness be present.

(RMDQ) to limit the potential for floor effects.6 Participants will be excluded if they (1) present with specific
spinal pathology (tumour, spondylolythesis, fracture,
etc), nerve root pain or co-existing major muscular,
joint, neurological or psychiatric conditions; (2) have
undergone back surgery; (3) are currently undertaking
a structured exercise programme for LBP; or (4) present
with contraindications to tDCS (eg, cuts or blisters under
the electrode sites) or conditioned pain modulation techniques (eg, loss of sensation). Participants can continue
to use their normal medication for the duration of the
trial. The type of medication and dosage used will be
recorded at the baseline assessment.

Methods and analysis
Trial design
We will use a pilot randomised, participant and assessor-blind controlled trial design. The trial will be
conducted and reported according to the Consolidated
Standards of Reporting Trials (CONSORT) statement
for non-pharmacological treatment standards and the
Template for Intervention Description and Replication
checklist and guide.32 The trial has been prospectively
registered with the Australian and New Zealand Clinical
Trials Registry (ACTRN12616000624482).

Blinding
Participants, the therapist and the outcome assessor
will be blind to group allocation. The tDCS unit used to
deliver the direct current stimulation includes a blinded
study mode that allows the therapist to enter only a
blinded randomisation code to determine whether
active or sham stimulation is delivered. Set-up of the
randomisation code, and programming of the tDCS
unit, will be performed by an investigator not involved
in the trial. The success of participant blinding will be
assessed at follow-up assessment using a yes/no response
to the question, ‘Do you feel you received the real brain
stimulation?’ and a 10 cm visual analogue scale of the
individual’s confidence in that judgement.35 36 Participants will also be asked, ‘Why do you believe you received
the real/sham brain stimulation?’ and, ‘Was it divulged
to you whether you were receiving real brain stimulation
or not?’ The success of therapist and assessor blinding
will be determined at the completion of the follow-up
assessment for each participant using a yes/no response
to the question, ‘Did you know the intervention group to

Participants
Participants aged between 18 and 60 years with chronic
LBP will be recruited from the Western Sydney suburbs,
in New South Wales, Australia. Chronic LBP is defined as
pain occurring between the bottom rib and the gluteal
fold, which has been present for more than 12 weeks.2 4 33
Participants will be required to have an average pain score
greater than or equal to 4/10 on a numerical rating scale
in the week prior to enrolment34 and a minimum score of
4 points on the Roland Morris Disability Questionnaire
2

Recruitment
Participants will be recruited from local healthcare
providers (eg, medical practitioners, chiropractors and
physiotherapists), support groups, social media and newspaper advertisements. Potential participants will first
complete an online screening questionnaire with those
who meet the inclusion criteria contacted by the investigators to arrange baseline assessment. Participants will
then provide written informed consent on arrival at the
baseline assessment. The number of people screened and
enrolled in the trial, as well as reasons for ineligibility, will
be recorded.
Randomisation
Participants will be individually randomised on a 1:1 basis
to the active or control groups in equal numbers. The
randomisation schedule will be concealed in consecutively
numbered, sealed opaque envelopes. An investigator not
involved in recruitment, treatment or assessment will
provide the envelope to the treating clinician who will
reveal group allocation.
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which the participant was assigned before trial completion?’ and, ‘If you answer "yes", how was it divulged to
you?’.35
Intervention
Participants will be randomly allocated to receive either
(1) active tDCS + sensorimotor retraining or (2) sham
tDCS + sensorimotor retraining. The intervention will
be delivered twice a week for 10 weeks and will consist
of 20 min of active or sham tDCS immediately followed
by 1 hour of supervised sensorimotor retraining. A
10-week intervention has been chosen as this duration
has led to improved outcomes in people with chronic
LBP following a sensorimotor retraining intervention in
a previous study.6 A qualified physiotherapist, trained in
the use of tDCS, will deliver both the tDCS intervention
and the sensorimotor retraining in a consulting room of
Western Sydney University. To replicate typical clinical
practice, participants in both groups will also complete
home exercise three times per week. Outcome measures
will be assessed immediately before and immediately after
the 10-week intervention.
Transcranial direct current stimulation
tDCS will be delivered to the primary motor cortex using
a DC-STIMULATOR PLUS, (NeuroConn, Ilmenau,
Germany), while participants are comfortably and quietly
seated. Direct current will be delivered for 20 min via two
35 cm2 surface sponge electrodes. The active electrode
(anode) will be positioned over the primary motor cortex
using the International 10–20 system contralateral to the
side of worst LBP. The reference electrode (cathode)
will be positioned over the contralateral supraorbital
region ipsilateral to the side of pain. The primary motor
cortex has emerged as one of the most effective and reliable sites for tDCS in the treatment of pain, producing
improvements in pain analogous to those of FDA-approved pharmaceuticals in other musculoskeletal pain
conditions with considerably fewer side effects.25 Using
standard tDCS parameters,25 current intensity will be
ramped up (0–1 mA) and down (1–0 mA) over 10 s at the
beginning and end of the 20 min stimulation period. For
sham stimulation, electrodes will be placed in an identical
position. To provide the initial itching sensation, stimulation will be turned on for 15 s and then off. Participants
will be informed that they may or may not perceive any
sensation during the treatment. This procedure has been
shown to effectively blind participants to the stimulation
condition at intensities of 1 mA.37

movement training (including full range movements,
isometric local muscle recruitment and co-contraction
and dissociation exercises) and precision focused and
feedback enriched functional retraining.6 Five stages exist
for each of the sensory and motor retraining elements.
Participants will be progressed through each stage by the
physiotherapist based on specific, previously published
criteria.6
Participants will be provided with a home exercise diary
containing visual and written instructions for each exercise (including dosage) and will be asked to practice the
training at home for 30 min, 3 times per week. The exercise diary will include space for participants to outline
which exercises were completed, how many repetitions
were performed and any comments regarding the home
exercise programme (eg, whether pain was present,
whether any exercises were difficult and if applicable, the
reason why exercises were unable to be completed). The
exercise diary will be returned to the investigator at the
postintervention assessment session.

Outcome measures
Measures of feasibility, safety and adherence will be
collected throughout the pilot study, while endpoint
measures of pain and function (Brief Pain Inventory, RMDQ) as well as pain mechanisms will be measured
1 week prior to the participant commencing, and within
1 week of completion, of the 10-week intervention. All
measures will be performed in the research laboratories
of Western Sydney University.
Primary outcomes
Feasibility
The number of participants that (1) meet the inclusion
criteria, (2) agree to be randomised, (3) complete the
intervention and (4) attend the postintervention assessment will be calculated in accordance with CONSORT
guidelines. Feasibility will be measured as (1) the number
of treatment sessions attended by each participant, (2)
number of drop-outs in each group, (3) proportion of
participants recruited from the total number screened,
(4) willingness of each participant to undergo therapy on
an 11-point numerical rating scale with ‘not at all willing’
at 0 and ‘very willing’ at 10 (measured at baseline) and
(5) the number of home exercise sessions completed.

Sensorimotor retraining
Immediately following the active or sham tDCS intervention, participants will commence a graded sensorimotor
retraining programme informed by a previously published
protocol.6 7 Components of the protocol include progressive tactile localisation, tactile discrimination and
graphaesthesia training, laterality recognition, imagined
movements, precision focused and feedback enriched

Safety
Safety will be assessed as any adverse effect, defined as ‘a
response to an intervention which is noxious and unintended, and which occurs at doses normally used in man
for the prophylaxis, diagnosis, or therapy of disease, or for
the modification of physiological function’ and that likely
has a causal relationship with the intervention,38 reported
on verbal questioning by the treating physiotherapist at
each session. A mild tingling or itching sensation under
the electrodes, fatigue, headache, nausea and insomnia
have been reported as potential adverse reactions
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following tDCS.39 Potential adverse reactions as a result
of sensorimotor retraining may include increased pain
or muscle soreness in the back. The treating physiotherapist will record a description of any adverse effects along
with the severity and duration of symptoms and how the
adverse effect was managed.
Secondary outcomes
Questionnaires
The Brief Pain Inventory will be used to measure pain
severity and disability. To assess pain, participants will be
asked to complete four numerical rating scales anchored
with 0 (‘no pain’) and 10 (‘worst pain imaginable’) for
pain at its (1) most intense over the last week, (2) least
intense over the last week, (3) average intensity over the
last week and (4) right now. Scores from each scale will
be averaged to calculate a final pain severity score out of
10.40 To assess function, participants will complete seven
numerical rating scales to describe how their back pain
interfered with daily life (eg, general activity and mood)
in the past week. Each scale will be anchored with 0 (‘does
not interfere with daily life’) and 10 (‘completely interferes’). Scores from the seven scales will be averaged to
give a final pain interference score out of 10.41 The Brief
Pain Inventory has been shown to be valid and reliable
in the chronic LBP population.40 Self-reported disability
will also be measured using the 24-point RMDQ that
has been shown to be valid and reliable in people with
LBP.42 43 Finally, the global perceived effect of treatment
scale, where each participant’s perceived response to
therapy is assessed using an 11-point Likert scale ranging
from ‘vastly worsened’ to ‘completely recovered’, will be
completed.44
Measures of pain mechanisms
Measures of pain mechanisms will be performed in the
same order for all participants.
Secondary outcomes of pain mechanisms
Pressure pain thresholds (PPTs)
Pressure pain thresholds (PPTs) will be measured using
a hand-held pressure algometer (Algometer Type II,
SBMEDIC Electronics, Sweden) with a probe size of
1 cm2. The probe will be applied perpendicular to the
skin (rate 40 kPa/s) until the participant first reports
that the sensation of pressure has changed to pain.
PPTs will be measured three times, in random order, at
each of nine sites on a 3×3 grid (spacing 2 cm between
points, 27 stimuli in total) centred at the site of worst
pain. Participants will be asked to locate the site of worst
pain at baseline for positioning of the grid. The location of this site will be recorded using bony landmarks
to ensure that the same site is targeted in the follow-up
assessment. In addition, three PPTs will be measured at
the contralateral thumbnail. The average of the three
measurements at each site will be used for analyses. PPT
measures have been shown to be reliable in chronic
LBP.45 46
4

Heat pain thresholds
Heat pain thresholds (HPT) will be measured using
a Thermal Sensory Analyzer system (TSA-2001,
Q-Sens-CPM, Medoc, Ramat Yishai, Israel). A 30×30 mm
Peltier-based thermode will be placed on the skin. The
temperature will start at 32°C and increase at a rate of
0.5 °C/s. Participants will push a button when the sensation of heat first turns to a sensation of pain. HPTs will be
measured at (1) the site of worst pain, (2) the lumbar site
contralateral to the side of pain and (3) the ventral aspect
of the forearm contralateral to the side of pain (10 cm
distal from the elbow crest). Three measurements will
be recorded at each site and the average analysed. HPT
measures are reliable in chronic LBP.45 47
Conditioned pain modulation
Conditioned pain modulation (CPM) is examined as a
change in the pain perceived in one body region (test
stimulation) as a result of pain induced in another body
region (conditioned stimulation). It is a safe measure of
pain processing that is thought to indicate the function of
descending pain control systems. We will use pressure pain
(PPTs) as the test stimulation and heat pain (1°C above
HPT) as the conditioned stimulation (Thermal Sensory
Analyzer, TSA-2001, Q-Sense-CPM, Medoc, Ramat Yishai,
Israel). Three PPTs will be measured before the application of heat pain. Heat pain will then be applied via a
30×30 mm thermode with three sequential PPT measures
taken after 30 s of the conditioning (heat) stimulus. The
heat stimulus will then be removed. Participants will be
asked to rate their pain during conditioning (heat) stimulation on a numeric rating scale (0–100) at 0 s, 30 s and
at the end of the trial. Pain scores will be maintained
between 50 and 80/100 for the conditioned stimulus
during testing. Participants will complete two trials in
random order: (1) test stimulation applied at the most
painful lumbar region (indicated by the participant) and
conditioned stimulation at the contralateral forearm
and (2) test stimulation at the forearm ipsilateral to the
site of pain and conditioned stimulation at the contralateral lumbar region. The CPM paradigm is reliable in
chronic LBP.45 48 49
Temporal summation
Temporal summation (TS) will be assessed using a 26 g
nylon monofilament (Aesthesio: DanMic Global) to
apply repeated mechanical stimulation according to the
Standardized Evaluation of Pain protocol.50 The participant will be asked whether a single filament stimulus
provokes pain. If the answer is ‘yes’, the participant will
then be asked to rate the pain on a numeric rating scale
(0–100). If the answer is ‘no’, a ‘zero’ will be recorded on
a numeric rating scale. The filament will then be applied
to the skin at a rate of 1 Hz for 30 s. The participant will be
asked to rate the pain on the numeric rating scale again
at the end of the 30 stimuli. TS will be tested on the most
painful area and the dorsal aspect of the non-dominant
wrist joint. Previous work has recommended using TS of
Ouellette AL, et al. BMJ Open 2017;7:e013080. doi:10.1136/bmjopen-2016-013080
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mechanical pain to assess endogenous pain modulation
in chronic LBP populations.51 TS of mechanical pain is a
reliable test.52
Data and statistical analyses
Data for feasibility and safety will be analysed using
descriptive statistics. Trends for effectiveness will be determined in two ways: (1) to assess within group changes
in pain, function and pain mechanisms, a one-way
repeated measures analysis of variance will be performed
to compare baseline and 10-week follow-up scores for
each outcome, in each group; (2) to assess betweengroup changes in pain, function and pain mechanisms,
an analysis of covariance will be performed where group
allocation is the fixed factor and the corresponding baseline outcome values are included as covariates.53 Post hoc
Bonferroni tests will be applied where appropriate. Effect
sizes will be determined using partial η2 from planned
contrasts. Alpha will be set at 0.05. As this is a pilot trial,
missing data will not be replaced.
The size of the treatment effects will be used to
determine whether a full randomised controlled trial
is warranted.54 55 Means and SD for measures of pain,
disability and pain mechanisms will be used to perform
a sample size estimate. Power will be set at 80% to detect
between-group differences with an alpha of 0.05 and a
drop-out rate based on that of the pilot trial. SigmaPlot
software will be used to analyse all data.
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